Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 690

    1.

    Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.

    Mariat C, Venet C, Jehl F, Mwewa S, Lazarevic V, Diconne E, Fonsale N, Carricajo A, Guyomarc'h S, Vermesch R, Aubert G, Bidault R, Bertrand JC, Zeni F.

    Crit Care. 2006 Feb;10(1):R26.PMID: 16507147 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Clearance of ceftazidime during continuous venovenous haemofiltration in critically ill patients.

    Traunmüller F, Schenk P, Mittermeyer C, Thalhammer-Scherrer R, Ratheiser K, Thalhammer F.

    J Antimicrob Chemother. 2002 Jan;49(1):129-34.PMID: 11751776 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.

    Guenter SG, Iven H, Boos C, Bruch HP, Muhl E.

    Pharmacotherapy. 2002 Feb;22(2):175-83.PMID: 11837556 [PubMed - indexed for MEDLINE]Related articles

    4.

    Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.

    Boereboom FT, Ververs FF, Blankestijn PJ, Savelkoul TJ, van Dijk A.

    Intensive Care Med. 1999 Oct;25(10):1100-4.PMID: 10551965 [PubMed - indexed for MEDLINE]Related articles

    5.

    Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections.

    Benko AS, Cappelletty DM, Kruse JA, Rybak MJ.

    Antimicrob Agents Chemother. 1996 Mar;40(3):691-5.PMID: 8851594 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.

    Giles LJ, Jennings AC, Thomson AH, Creed G, Beale RJ, McLuckie A.

    Crit Care Med. 2000 Mar;28(3):632-7.PMID: 10752806 [PubMed - indexed for MEDLINE]Related articles

    7.

    Pharmacokinetic modeling and dosage adaptation of biapenem in Japanese patients during continuous venovenous hemodiafiltration.

    Ikawa K, Morikawa N, Ikeda K, Suyama H.

    J Infect Chemother. 2008 Feb;14(1):35-9. Epub 2008 Feb 24.PMID: 18297447 [PubMed - indexed for MEDLINE]Related articles

    8.

    Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.

    DelDot ME, Lipman J, Tett SE.

    Br J Clin Pharmacol. 2004 Sep;58(3):259-68.PMID: 15327585 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.

    Fuhrmann V, Schenk P, Jaeger W, Miksits M, Kneidinger N, Warszawska J, Holzinger U, Kitzberger R, Thalhammer F.

    J Antimicrob Chemother. 2007 Nov;60(5):1085-90. Epub 2007 Sep 13.PMID: 17855725 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration.

    Fuhrmann V, Schenk P, Jaeger W, Ahmed S, Thalhammer F.

    J Antimicrob Chemother. 2004 Oct;54(4):780-4. Epub 2004 Sep 3.PMID: 15347636 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients.

    Robatel C, Decosterd LA, Biollaz J, Eckert P, Schaller MD, Buclin T.

    J Clin Pharmacol. 2003 Dec;43(12):1329-40.PMID: 14615469 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients.

    Malone RS, Fish DN, Abraham E, Teitelbaum I.

    Antimicrob Agents Chemother. 2001 Nov;45(11):3148-55.PMID: 11600370 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.

    Fish DN, Teitelbaum I, Abraham E.

    Antimicrob Agents Chemother. 2005 Jun;49(6):2421-8.PMID: 15917542 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration.

    Wallis SC, Mullany DV, Lipman J, Rickard CM, Daley PJ.

    Intensive Care Med. 2001 Apr;27(4):665-72.PMID: 11398692 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.

    Isla A, Gascón AR, Maynar J, Arzuaga A, Toral D, Pedraz JL.

    Clin Ther. 2005 May;27(5):599-608.PMID: 15978309 [PubMed - indexed for MEDLINE]Related articles

    16.

    Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.

    Tegeder I, Neumann F, Bremer F, Brune K, Lötsch J, Geisslinger G.

    Clin Pharmacol Ther. 1999 Jan;65(1):50-7.PMID: 9951430 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections.

    Buijk SL, Gyssens IC, Mouton JW, Van Vliet A, Verbrugh HA, Bruining HA.

    J Antimicrob Chemother. 2002 Jan;49(1):121-8.PMID: 11751775 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.

    Mouton JW, Horrevorts AM, Mulder PG, Prens EP, Michel MF.

    Antimicrob Agents Chemother. 1990 Dec;34(12):2307-11.PMID: 2088186 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    [Pharmacodynamic interest of ceftazidime continuous infusion vs intermittent bolus administration in patients with severe nosocomial pneumonia]

    Cousson J, Floch T, Vernet-Garnier V, Appriou M, Petit JS, Jovenin N, Lamiable D, Hoizey G.

    Pathol Biol (Paris). 2005 Oct-Nov;53(8-9):546-50. Epub 2005 Jul 14. French. PMID: 16023303 [PubMed - indexed for MEDLINE]Related articles

    20.

    Elimination of the piperacillin/tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure.

    Valtonen M, Tiula E, Takkunen O, Backman JT, Neuvonen PJ.

    J Antimicrob Chemother. 2001 Dec;48(6):881-5.PMID: 11733473 [PubMed - indexed for MEDLINE]Related articlesFree article